DVA DaVita Inc. Common Stock
$179,90
Preço · Ago 19, 2026
Fundamentais a partir de Ago 4, 2026
Intervalo 52 Semanas
$101–$247
54% of range
Classificação do Analista
HOLD
13 analysts
Preço-Alvo
$218
+21% upside
P/E (TTM)
18.5
ROE
-281.8%
Margem de Lucro Líquido
5.5%
Sobre DaVita Inc. Common Stock Visão geral da empresa da Wikipedia
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
Ler mais
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language), incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients (36% of the total of 557,000 patients in the U.S.), and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.
History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
Acquisitions and divestments
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
Legal issues
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
DVA Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$179.90
Capitalização de Mercado
$12.45B
P/E (TTM)
18.5
EPS (TTM)
$9.84
Receita (TTM)
$13.64B
Rendimento div.
0.00%
ROE
-281.8%
Dívida/Capital
—
Intervalo 52 Semanas
$101 – $247
DVA Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$13.64B
2016-12-31
→
2025-12-31
EPS
$9.84
2016-12-31
→
2025-12-31
Fluxo de caixa livre
$1.31B
2016-12-31
→
2025-12-31
Margens
5.5%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
DVA
Mediana de Pares
P/E (TTM)
18.5
32.6
P/S (TTM)
0.9
2.0
P/B
-19.1
4.4
Price / FCF (Preço / FCF)
9.5
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
DVA
Mediana de Pares
Operating Margin (Margem Operacional)
15.0%
—
Net Profit Margin (Margem de Lucro Líquido)
5.5%
2.4%
ROA
4.3%
4.5%
ROE
-281.8%
10.9%
ROIC
-245.6%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
DVA
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
1.3
1.7
Quick Ratio (Índice de Liquidez Seca)
1.0
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
DVA
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
6.5%
—
Revenue CAGR 3Y (CAGR Receita 3A)
5.5%
—
Revenue CAGR 5Y (CAGR Receita 5A)
3.4%
—
EPS YoY
-8.3%
—
Net Income YoY (Lucro Líquido Ano a Ano)
-20.2%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
DVA
Mediana de Pares
Payout Ratio (Índice de Pagamento)
0.00%
—
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
Dividend Yield
0.00%
Índice de Pagamento
0.00%
CAGR Dividendos 5 anos
—
DVA Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
MANTER
13 analistas
- Compra forte 1 7,7%
- Compra 5 38,5%
- Manter 6 46,2%
- Venda 1 7,7%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
7 analistas · 2026-08-16
Mediana
$220.00
Agora
$179.90
Mín
$165.00
Máx
$270.00
Alvo mediano
$220.00
+22,3%
Alvo médio
$218.43
+21,4%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-0.04%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $4.02 | $3.92 | 0.10% |
| 31 de Março de 2026 | $2.87 | $2.34 | 0.53% |
| 31 de Dezembro de 2025 | $3.40 | $3.19 | 0.21% |
| 30 de Setembro de 2025 | $2.04 | $3.25 | -1.2% |
| 30 de Junho de 2025 | $2.95 | $2.83 | 0.12% |
| 31 de Março de 2025 | $2.00 | $1.97 | 0.03% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Balanço Patrimonial 27
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Fluxo de Caixa 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Eficiência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Taxas de Crescimento 9
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Demonstração de Resultados 13
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | -153,159,000 | 72,075,000 | 75,943,000 | 79,368,000 | -173,404,000 | 83,721,000 | 86,899,000 | 87,775,000 | -182,013,000 | 91,322,000 | 90,984,000 | 90,497,000 | -188,967,000 | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | -156,521,000 | 73,769,000 | 77,362,000 | 81,275,000 | -178,018,000 | 85,795,000 | 88,950,000 | 90,547,000 | -186,760,000 | 94,041,000 | 93,418,000 | 92,483,000 | -195,704,000 | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Balanço Patrimonial 26
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Fluxo de Caixa 14
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Avaliação (TTM) 9
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.77B | $13.44B | · | $13.29B | $13.05B | $12.74B | · | $12.64B | $12.38B | $12.06B | · | $11.94B | $11.75B | $11.57B | · | $11.63B | |
| Net Income TTM | $813M | $710M | · | $727M | $800M | $840M | · | $924M | $888M | $781M | · | $646M | $624M | $608M | · | $752M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 19.3 | 16.2 | · | 14.6 | 14.9 | 15.9 | · | 16.0 | 14.3 | 16.4 | · | 13.7 | 15.2 | 12.9 | · | 11.2 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.0 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| P / FCF | · | 48.6 | · | · | · | 321.7 | · | · | · | -48.5 | · | · | · | 23.4 | · | · | |
| Earnings Yield | 5.2% | 6.2% | · | 6.9% | 6.7% | 6.3% | · | 6.3% | 7.0% | 6.1% | · | 7.3% | 6.6% | 7.8% | · | 8.9% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Margem Operacional % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Lucro líquido | $747M | $936M | $692M | $560M | $978M |
| EPS Diluído | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Índice de Liquidez Seca | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 698 declarantes · $7.9B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 131 (-1 vs trimestre anterior) | 59 (-5 vs trimestre anterior) | 184 (+11 vs trimestre anterior) | 217 (+12 vs trimestre anterior) | +3.7M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $3.331.328.308 | 14.973.608 | 42,04% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $467.525.034 | 2.101.425 | 5,90% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306.558.307 | 1.377.914 | 3,87% | Ações |
| STATE STREET CORP | $294.345.267 | 1.323.019 | 3,71% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $235.869.514 | 1.060.183 | 2,98% | Ações |
| NEUBERGER BERMAN GROUP LLC | $199.315.922 | 896.621 | 2,52% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197.802.963 | 889.082 | 2,50% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $165.824.664 | 746.907 | 2,09% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163.166.832 | 733.400 | 2,06% | Opção de compra |
| Gates Capital Management, Inc. | $153.096.497 | 688.136 | 1,93% | Ações |
| BANK OF AMERICA CORP /DE/ | $133.302.007 | 599.164 | 1,68% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81.331.791 | 365.569 | 1,03% | Ações |
| NORGES BANK | $76.627.007 | 344.422 | 0,97% | Ações |
| NORDEA INVESTMENT MANAGEMENT AB | $67.404.554 | 305.067 | 0,85% | Ações |
| GOLDMAN SACHS GROUP INC | $63.752.756 | 286.555 | 0,80% | Ações |
| D. E. Shaw & Co., Inc. | $62.040.995 | 278.861 | 0,78% | Ações |
| JANE STREET GROUP, LLC | $53.573.184 | 240.800 | 0,68% | Opção de compra |
| Holocene Advisors, LP | $52.875.709 | 237.665 | 0,67% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.100.176 | 216.200 | 0,61% | Opção de venda |
| Quantinno Capital Management LP | $45.366.106 | 203.910 | 0,57% | Ações |
| CITADEL ADVISORS LLC | $44.465.298 | 199.862 | 0,56% | Ações |
| CITADEL ADVISORS LLC | $44.184.528 | 198.600 | 0,56% | Opção de compra |
| VANGUARD FIDUCIARY TRUST CO | $40.134.502 | 180.396 | 0,51% | Ações |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37.089.700 | 241.328 | 0,47% | Ações |
| Gotham Asset Management, LLC | $36.393.278 | 163.580 | 0,46% | Ações |
| JANE STREET GROUP, LLC | $35.774.784 | 160.800 | 0,45% | Opção de venda |
| Doma Perpetual Capital Management LLC | $35.522.937 | 159.668 | 0,45% | Ações |
| FIRST TRUST ADVISORS LP | $34.161.205 | 153.548 | 0,43% | Ações |
| TODD ASSET MANAGEMENT LLC | $32.697.663 | 146.969 | 0,41% | Ações |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32.011.312 | 143.884 | 0,40% | Ações |
| Allianz Asset Management GmbH | $30.236.367 | 135.906 | 0,38% | Ações |
| MORGAN STANLEY | $28.624.054 | 128.659 | 0,36% | Ações |
| Toroso Investments, LLC | $28.283.664 | 248.954 | 0,36% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $26.480.460 | 119.024 | 0,33% | Ações |
| BlackRock, Inc. | $26.457.544 | 118.921 | 0,33% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $26.377.896 | 118.563 | 0,33% | Ações |
| Amundi | $25.967.198 | 116.717 | 0,33% | Ações |
| BARCLAYS PLC | $25.933.826 | 116.567 | 0,33% | Ações |
| Davidson Kempner Capital Management LP | $25.162.043 | 113.098 | 0,32% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $23.582.658 | 105.999 | 0,30% | Ações |
| VANGUARD GROUP INC | $23.117.136 | 203.478 | 0,29% | Ações |
| RHUMBLINE ADVISERS | $23.076.629 | 103.725 | 0,29% | Ações |
| Woodline Partners LP | $22.872.501 | 102.807 | 0,29% | Ações |
| UBS Group AG | $20.846.376 | 93.700 | 0,26% | Opção de venda |
| MILLENNIUM MANAGEMENT LLC | $20.579.400 | 92.500 | 0,26% | Opção de venda |
| FMR LLC | $20.183.608 | 90.721 | 0,25% | Ações |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $19.532.854 | 87.796 | 0,25% | Ações |
| MILLENNIUM MANAGEMENT LLC | $17.151.873 | 77.094 | 0,22% | Ações |
| California Public Employees Retirement System | $15.370.253 | 69.086 | 0,19% | Ações |
| Swiss National Bank | $14.906.160 | 67.000 | 0,19% | Ações |
| Vanguard Global Advisers, LLC | $14.696.806 | 66.059 | 0,19% | Ações |
| WOLVERINE TRADING, LLC | $14.482.431 | 110.900 | 0,18% | Opção de venda |
| National Philanthropic Trust | $14.000.889 | 62.931 | 0,18% | Ações |
| PineBridge Investments, L.P. | $13.874.153 | 104.419 | 0,18% | Ações |
| TUDOR INVESTMENT CORP ET AL | $13.325.440 | 59.895 | 0,17% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $13.022.644 | 58.534 | 0,16% | Ações |
| Candriam S.C.A. | $12.727.615 | 57.263 | 0,16% | Ações |
| DANSKE BANK A/S | $12.471.116 | 56.055 | 0,16% | Ações |
| CITADEL ADVISORS LLC | $12.280.896 | 55.200 | 0,15% | Opção de venda |
| Susquehanna Portfolio Strategies, LLC | $12.219.714 | 54.925 | 0,15% | Ações |
| MILLENNIUM MANAGEMENT LLC | $11.902.680 | 53.500 | 0,15% | Opção de compra |
| STOREBRAND ASSET MANAGEMENT AS | $11.500.659 | 51.693 | 0,15% | Ações |
| LPL Financial LLC | $10.778.934 | 48.449 | 0,14% | Ações |
| Robeco Institutional Asset Management B.V. | $10.083.684 | 45.324 | 0,13% | Ações |
| Callahan Advisors, LLC | $10.033.403 | 45.098 | 0,13% | Ações |
| Assenagon Asset Management S.A. | $9.963.322 | 44.783 | 0,13% | Ações |
| Verition Fund Management LLC | $9.740.174 | 43.780 | 0,12% | Ações |
| Prospera Financial Services Inc | $9.482.479 | 42.623 | 0,12% | Ações |
| Te Ahumairangi Investment Management Ltd | $9.480.318 | 42.612 | 0,12% | Ações |
| SEI INVESTMENTS CO | $9.251.830 | 41.585 | 0,12% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $9.207.557 | 41.386 | 0,12% | Ações |
| Inlet Private Wealth, LLC | $9.004.878 | 40.475 | 0,11% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $8.835.126 | 39.712 | 0,11% | Ações |
| Caisse de depot et placement du Quebec | $8.721.216 | 39.200 | 0,11% | Ações |
| Twin Tree Management, LP | $8.454.240 | 38.000 | 0,11% | Opção de compra |
| Brevan Howard Capital Management LP | $8.343.000 | 37.500 | 0,11% | Opção de compra |
| CITIGROUP INC | $8.298.504 | 37.300 | 0,10% | Opção de venda |
| NISA INVESTMENT ADVISORS, LLC | $7.947.431 | 35.722 | 0,10% | Ações |
| IEQ CAPITAL, LLC | $7.900.154 | 35.510 | 0,10% | Ações |
| UBS Group AG | $7.386.336 | 33.200 | 0,09% | Opção de compra |
| Counterpoint Mutual Funds LLC | $7.384.111 | 33.190 | 0,09% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $7.170.308 | 32.229 | 0,09% | Ações |
| FIFTH THIRD BANCORP | $7.074.159 | 31.797 | 0,09% | Ações |
| Summit Trail Advisors, LLC | $7.043.272 | 31.658 | 0,09% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $6.953.397 | 45.243 | 0,09% | Ações |
| Corient Private Wealth LP | $6.916.838 | 31.117 | 0,09% | Ações |
| Tredje AP-fonden | $6.780.968 | 30.479 | 0,09% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $6.656.824 | 29.921 | 0,08% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6.539.132 | 29.392 | 0,08% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.407.202 | 28.799 | 0,08% | Ações |
| NATIONAL BANK OF CANADA /FI/ | $6.204.782 | 27.888 | 0,08% | Ações |
| Walleye Capital LLC | $6.184.944 | 27.800 | 0,08% | Opção de compra |
| GHP Investment Advisors, Inc. | $6.107.487 | 39.739 | 0,08% | Ações |
| Wakefield Asset Management LLLP | $5.893.051 | 26.488 | 0,07% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $5.749.551 | 25.843 | 0,07% | Ações |
| ALLIANCEBERNSTEIN L.P. | $5.566.805 | 36.221 | 0,07% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $5.507.937 | 24.757 | 0,07% | Ações |
| CWA Asset Management Group, LLC | $5.003.575 | 22.490 | 0,06% | Ações |
| Legal & General Group Plc | $4.992.452 | 22.440 | 0,06% | Ações |
| Mitsubishi UFJ Trust & Banking Corp | $4.942.393 | 22.215 | 0,06% | Ações |
Executivos da empresa 59 insiders · 31 diretores · 25 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 16 de Junho de 2026 S | 840.408 | 0 | 2 | $-14.532.097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 17 de Maio de 2016 S | 18.766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 7 de Maio de 2026 S | 132.434 | 0 | 1 | $-9.887.579 |
| Luis Borgen | Chief Financial Officer | 22 de Março de 2012 M | 18.517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 31 de Março de 2010 A | 33.604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 14 de Março de 2007 A | 31.250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 1 de Julho de 2006 A | 10.000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 12 de Maio de 2026 S | 94.105 | 0 | 2 | $-4.089.696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 16 de Agosto de 2024 S | 209.365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 24 de Dezembro de 2016 A | 4.688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 15 de Junho de 2026 S | 109.194 | 0 | 2 | $-3.210.360 |
| James O Hearty | Chief Compliance Officer | 14 de Maio de 2026 M | 22.389 | 0 | 2 | $-3.291.616 |
| Christopher Michael Berry | Chief Accounting Officer | 15 de Março de 2026 A | 19.640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 15 de Março de 2023 F | 15.676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 18 de Setembro de 2020 M | 24.590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 1 de Junho de 2020 F | 110.462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 2 de Junho de 2019 F | 33.125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 13 de Junho de 2017 M | 3.514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 22 de Setembro de 2015 M | 7.438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 4 de Junho de 2015 S | 2.322.928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 13 de Fevereiro de 2014 M | 8.990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 9 de Setembro de 2013 A | — | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 2 de Agosto de 2013 G | 2.315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 29 de Fevereiro de 2012 M | 17.491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 17 de Junho de 2009 M | 5.547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 13 de Fevereiro de 2009 M | 2.084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 11 de Agosto de 2008 M | 2.500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 5 de Março de 2008 A | — | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 16 de Julho de 2007 A | 6.250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 8 de Maio de 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 4 de Novembro de 2005 M | 42.000 | 0 | 0 | $0 |
| Dennis W Pullin | Conselheiro | 15 de Agosto de 2026 A | 2.949 | 0 | 0 | $0 |
| Gregory J. Moore | Conselheiro | 15 de Agosto de 2026 A | 8.091 | 0 | 0 | $0 |
| Jason M. Hollar | Conselheiro | 15 de Agosto de 2026 A | 6.883 | 0 | 0 | $0 |
| Patricia M Arway | Conselheiro | 15 de Agosto de 2026 A | 27.223 | 0 | 0 | $0 |
| Adam H Schechter | Conselheiro | 15 de Agosto de 2026 A | 5.970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Conselheiro | 15 de Agosto de 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Conselheiro | 15 de Agosto de 2026 A | 9.803 | 0 | 0 | $0 |
| Barbara J Desoer | Conselheiro | 15 de Agosto de 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Conselheiro | 15 de Maio de 2025 A | 19.982 | 0 | 0 | $0 |
| John M Nehra | Conselheiro | 15 de Maio de 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Conselheiro | 15 de Maio de 2023 A | 16.069 | 0 | 0 | $0 |
| Paula A Price | Conselheiro | 15 de Maio de 2022 A | 1.395 | 0 | 0 | $0 |
| Shawn M Guertin | Conselheiro | 15 de Maio de 2021 A | 1.105 | 0 | 0 | $0 |
| Pascal Desroches | Conselheiro | 15 de Novembro de 2020 A | 8.030 | 0 | 0 | $0 |
| William L Roper | Conselheiro | 11 de Junho de 2020 A | 16.234 | 0 | 0 | $0 |
| Peter T Grauer | Conselheiro | 11 de Junho de 2020 A | 76.204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Conselheiro | 31 de Dezembro de 2017 A | 10.764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Conselheiro | 11 de Junho de 2012 A | 7.195 | 0 | 0 | $0 |
| Richard C Vaughan | Conselheiro | 13 de Maio de 2010 A | 6.092 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 declarações | 13 de Fevereiro de 2025 | 45,00% | Emenda | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 130 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 4,50% | 217.039 NS | 30 de Abril de 2026 | N-PORT |
| AZTD · Tidal Trust I | 2,74% | 7.761 NS | 30 de Abril de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,19% | 123.121 NS | 30 de Abril de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,40% | 59.690 SH | 8 de Agosto de 2026 | Diário |
| AGNG · Global X Funds | 0,92% | 3.855 NS | 31 de Maio de 2026 | N-PORT |
| IHF · iShares Trust | 0,86% | 58.907 SH | 8 de Agosto de 2026 | Diário |
| LSEQ · Harbor ETF Trust | 0,76% | 758 NS | 30 de Abril de 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,56% | 5.441 NS | 31 de Maio de 2026 | N-PORT |
| ITAN · EA Series Trust | 0,38% | 1.735 NS | 29 de Maio de 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,38% | 10.626 NS | 30 de Abril de 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,34% | 11.220 NS | 31 de Maio de 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,31% | 9.914 SH | 8 de Agosto de 2026 | Diário |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,30% | 2.502 NS | 31 de Maio de 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 0,30% | 352 NS | 30 de Abril de 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0,28% | 909.000 PA | 8 de Agosto de 2026 | Diário |
| DFVE · DoubleLine ETF Trust | 0,24% | 425 NS | 31 de Março de 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,24% | 22.988 SH | 8 de Agosto de 2026 | Diário |
| IQSM · New York Life Investments ETF Trust | 0,23% | 4.682 NS | 30 de Abril de 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,18% | 635 NS | 30 de Abril de 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,17% | 934.012 SH | 8 de Agosto de 2026 | Diário |
| VBR · VANGUARD INDEX FUNDS | 0,15% | 467.367 SH | 8 de Agosto de 2026 | Diário |
| BKMC · BNY Mellon ETF Trust | 0,14% | 5.728 NS | 30 de Abril de 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 1.975 NS | 30 de Abril de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,14% | 124.181 NS | 30 de Abril de 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 3.564 NS | 30 de Abril de 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,12% | 90.512 NS | 31 de Maio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,11% | 100.394 SH | 8 de Agosto de 2026 | Diário |
| ISCG · iShares Trust | 0,11% | 6.082 SH | 8 de Agosto de 2026 | Diário |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 14.233 NS | 30 de Abril de 2026 | N-PORT |
| ESML · iShares Trust | 0,10% | 15.995 SH | 8 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,10% | 17.983 NS | 30 de Abril de 2026 | N-PORT |
| ISCB · iShares Trust | 0,10% | 1.555 SH | 8 de Agosto de 2026 | Diário |
| IYH · iShares Trust | 0,09% | 19.255 SH | 8 de Agosto de 2026 | Diário |
| RXL · ProShares Trust | 0,09% | 348 NS | 31 de Maio de 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 3.622 SH | 8 de Agosto de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,09% | 736.199 SH | 8 de Agosto de 2026 | Diário |
| SMMD · iShares Trust | 0,08% | 16.234 SH | 8 de Agosto de 2026 | Diário |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,08% | 3.527 SH | 8 de Agosto de 2026 | Diário |
| CURE · Direxion Shares ETF Trust | 0,07% | 667 NS | 30 de Abril de 2026 | N-PORT |
| IXJ · iShares Trust | 0,07% | 16.934 SH | 8 de Agosto de 2026 | Diário |
| SMMV · iShares Trust | 0,07% | 1.125 SH | 8 de Agosto de 2026 | Diário |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,07% | 5.907 NS | 30 de Abril de 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,07% | 1.423 NS | 31 de Maio de 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,07% | 930 NS | 29 de Maio de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,06% | 33.893 SH | 8 de Agosto de 2026 | Diário |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 3.136 SH | 8 de Agosto de 2026 | Diário |
| WSML · iShares Trust | 0,05% | 1.985 SH | 8 de Agosto de 2026 | Diário |
| TILT · FlexShares Trust | 0,05% | 6.930 NS | 30 de Abril de 2026 | N-PORT |
| IWS · iShares Trust | 0,05% | 45.847 SH | 8 de Agosto de 2026 | Diário |
| DUHP · Dimensional ETF Trust | 0,04% | 32.462 NS | 30 de Abril de 2026 | N-PORT |